Science Explorer Back to mapMap
Discussion
Company · Freiburg · Germany

Actelion (Germany)

Research works
2
▼ 8% vs 2018-21
Citations
9
4.2 per fractional work
Top-10% rate
2.2%
all institutions 10.0%
Open access
46%
world 40%
International
61%
world 18%

Not ranked overall: Actelion (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Actelion (Germany) work in?

In all years, 67% of research at Actelion (Germany) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (29%), Psychology (5%). It does 1.3× the world's share of Health Sciences.

Life Sciences29%Health Sciences67%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Medicine166.7%
    1. Biochemistry, Genetics and Molecular Biology128.6%
    1. Psychology04.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at Actelion (Germany)?

Ranked on the quality score, Eugen von Philippovich lead among researchers whose main affiliation is Actelion (Germany).

  1. 1 Eugen von Philippovich Germany · #2,668,452 worldwide 98 citations · 30 works
All ranked researchers at Actelion (Germany)

What are the most cited papers from Actelion (Germany)?

The most cited paper from Actelion (Germany) is "The Endothelin Receptor Antagonist Macitentan Improves Isosorbide‐5‐Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation" (Sebastian Steven, Matthias Walter Oelze, Michael Hausding et al., 2018), with 21 citations. Next come "Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2" (20) and "Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions" (3).

Most cited papers
#PaperReleasedCitations
1 The Endothelin Receptor Antagonist Macitentan Improves Isosorbide‐5‐Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation Sebastian Steven, Matthias Walter Oelze, Michael Hausding et al. · Oxidative Medicine and Cellular Longevity Open access 2018 21
2 Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2 Liliane Todesco, Daniel Bur, Hilary Brooks et al. · Cellular and Molecular Life Sciences Open access 11 Apr 2008 20
3 Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions T. Barret, Bruno Degano, Hélène Bouvaist et al. · Journal of Cardiopulmonary Rehabilitation and Prevention 20 Mar 2023 3
4 182. Seltorexant, Adjunctive to Antidepressants, in Adults With Major Depressive Disorder With Insomnia Symptoms: Results of a Double-Blind, Randomized, Placebo-Controlled Study Michael E. Thase, Andrew D. Krystal, Ewa Wajs et al. · Biological Psychiatry 9 Apr 2025 2
5 SAT0284 EPIGENETIC DEREGULATION OF AUTOPHAGY PROMOTES FIBROSIS IN SYSTEMIC SCLEROSIS Ariella Zehender, Neng‐Yu Lin, Y. N. Li et al. · Annals of the Rheumatic Diseases Open access Jun 2020 2
All 9 most cited papers, with filters and sorting

Which research topics does Actelion (Germany) publish most on?

By volume in 2022-now: Sleep and related disorders, Pulmonary Hypertension Research and Treatments, Cardiovascular and exercise physiology and Chronic Obstructive Pulmonary Disease (COPD) Research.

  1. 1 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  2. 2 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  3. 3 Cardiovascular and exercise physiology Complementary and alternative medicine 0 works
  4. 4 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  5. 5 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  6. 6 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  7. 7 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  8. 8 Salivary Gland Disorders and Functions Physiology 0 works
  9. 9 Cancer-related molecular mechanisms research Cancer Research 0 works
  10. 10 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 40% of research is openly available.

with international co-authors61.0%domestic only39.0%

World: 18% is written across borders.

How has Actelion (Germany)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Freiburg

All research institutions in Freiburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Actelion (Germany). Posts are plain text and can be reported.